Cutera, Inc. (CUTR)
Stock Price Chart
Key Info
| Market Cap | 321.70M |
| Revenue (ttm) | 156.52M |
| Net Income (ttm) | -28.52M |
| Shares Out | 17.59M |
| EPS (ttm) | -1.91 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 29, 2020 |
| Last Price | $18.29 |
| Previous Close | $19.10 |
| Change ($) | -0.82 |
| Change (%) | -4.27% |
| Day's Open | 19.13 |
| Day's Range | 18.25 - 19.55 |
| Day's Volume | 52,183 |
| 52-Week Range | 9.07 - 39.15 |
More Stats
| Market Cap | 321.70M |
| Enterprise Value | 290.09M |
| Earnings Date (est) | Nov 4, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 17.59M |
| Float | 16.89M |
| EPS (basic) | -1.87 |
| EPS (diluted) | -1.91 |
| FCF / Share | -1.02 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 608,572 |
| Short Ratio | 2.32 |
| Short % of Float | 3.60% |
| Beta | 1.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 2.06 |
| PB Ratio | 7.12 |
| Revenue | 156.52M |
| Operating Income | -27.40M |
| Net Income | -28.52M |
| Free Cash Flow | -17.33M |
| Net Cash | 31.62M |
| Net Cash / Share | 1.80 |
| Gross Margin | 62.72% |
| Operating Margin | -17.50% |
| Profit Margin | -18.20% |
| FCF Margin | -11.07% |
| ROA | -14.68% |
| ROE | -59.62% |
| ROIC | -70.00% |
Analyst Forecasts
Analyst Consensus: Buy
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 182 | 163 | 151 | 118 | 94.76 | 78.14 | 74.59 | 77.28 | 60.29 | 53.27 |
| Revenue Growth | 11.67% | 7.41% | 28.32% | 24.58% | 21.27% | 4.75% | -3.47% | 28.18% | 13.17% | - |
| Gross Profit | 98.16 | 80.38 | 86.11 | 68.14 | 54.28 | 43.37 | 41.88 | 41.54 | 34.31 | 30.22 |
| Operating Income | -12.06 | -13.39 | 11.08 | 2.40 | -4.52 | -10.62 | -5.26 | -6.83 | -10.43 | -11.10 |
| Net Income | -12.35 | -30.77 | 29.99 | 2.58 | -4.44 | -10.61 | -4.75 | -6.55 | -10.06 | -10.52 |
| Shares Outstanding | 14.10 | 13.77 | 13.87 | 13.23 | 13.96 | 14.25 | 14.42 | 14.09 | 13.81 | 13.54 |
| Earnings Per Share | -0.88 | -2.23 | 2.04 | 0.19 | -0.32 | -0.74 | -0.33 | -0.46 | -0.73 | -0.78 |
| EPS Growth | - | - | 973.68% | - | - | - | - | - | - | - |
| Operating Cash Flow | -2.22 | 0.31 | 14.29 | 1.99 | -1.36 | -4.29 | 3.51 | -2.30 | -5.17 | -8.06 |
| Capital Expenditures | -0.95 | -1.45 | -0.80 | -0.52 | -0.75 | -0.73 | -0.61 | -0.52 | -0.72 | -0.28 |
| Free Cash Flow | -3.16 | -1.14 | 13.49 | 1.48 | -2.11 | -5.02 | 2.90 | -2.82 | -5.88 | -8.33 |
| Cash & Equivalents | 33.92 | 35.58 | 35.91 | 54.07 | 48.41 | 81.15 | 83.07 | 85.57 | 88.69 | 90.00 |
| Total Debt | 7.91 | - | - | - | - | - | - | - | - | - |
| Net Cash / Debt | 26.01 | 35.58 | 35.91 | 54.07 | 48.41 | 81.15 | 83.07 | 85.57 | 88.69 | 90.00 |
| Assets | 114 | 97.64 | 111 | 91.85 | 77.52 | 109 | 109 | 113 | 111 | 112 |
| Liabilities | 67.80 | 51.25 | 46.35 | 30.84 | 27.48 | 28.41 | 24.40 | 22.02 | 19.79 | 16.39 |
| Book Value | 45.94 | 46.39 | 64.89 | 61.01 | 50.03 | 80.51 | 84.27 | 90.77 | 91.57 | 95.42 |
Company Profile
Company Details
| Full Name | Cutera, Inc. |
| Country | United States |
| Employees | 447 |
| CEO | David H. Mowry |
Stock Information
| Ticker Symbol | CUTR |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Unique Identifier | NASDAQ: CUTR |
| IPO Date | March 31, 2004 |
Description
Cutera, a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.